General Info
Wouter Verhoeven is a venture partner at BGV since 2021. With over 15 years of Biotech experience, he primarily focuses on Pharmaceuticals, Consumer Health, Digital Health, BioTech, and Health & Hospital Services. His investment check size ranges from $100K to $1M, with a sweet spot at $500K. Geographically, his preference is in the Netherlands. Wouter’s professional career includes roles at Dualyx, Berna Biotech, Crucell, Rabo Private Equity, Mabxience, and NBE Therapeutics, with a background in business development. He holds a MSc in Technical Management from Delft University of Technology.
Location: Netherlands
Country: Netherlands
Industries:
Investment Regions: EU
Investment Stages: pre-seed, seed
angel-individual
EU
Want to start building warm intros with this investor?
🤖 AI Activity Report
Status: low-active
AI Reasoning: BGV site and press releases show Wouter Verhoeven (Dualyx CEO and BGV venture partner) participated in Dualyx’s Series A on May 15, 2023. The time since that investment is 17 months (from May 15, 2023 to current date), which is more than 12 months. Therefore classify as low-active. Startup invested: Dualyx.
Angel activity thresholds:
Low Activity – Only known angel investments more than 12 months ago.
Active – Known angel investments between the last 12 and 6 months.
Very Active – Known angel investments in the last 6 months.
Investor Contact
Team Members
Name
Role
Email
LinkedIn
…
…
…
…
…
Investment Regions Map
loading map…
Similar Investors
Other similar investors:
Latest on X (Twitter)
Access all contact details of Wouter Verhoeven

Gain instant access to partner names, verified emails, LinkedIn profiles, and more—all in one place. Dive into their portfolio founders and their LinkedIn information, so you can quickly start your outreach and look for warm intros.
Add custom tags to your investor cards. Label them by investment stage, industry focus, interest level, or any other criteria you want to stay organized.
Trusted by Founders like You
Find your matching investors using AI
